PubRank

B M Henz

Author PubWeight™ 97.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998 2.24
2 C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997 1.55
3 EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 1.55
4 Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol 2001 1.44
5 Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol 1999 1.40
6 [Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr 1998 1.38
7 EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 2006 1.28
8 Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders? Exp Dermatol 1999 1.13
9 Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996 1.10
10 Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 1996 1.09
11 Miliaria crystallina in an intensive care setting. Clin Exp Dermatol 2004 1.08
12 Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998 1.06
13 Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995 1.04
14 Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol 1997 1.03
15 Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res 1996 1.02
16 Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999 1.01
17 Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis. Allergy 2005 0.97
18 Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 2000 0.97
19 Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. Eur J Cancer 2003 0.97
20 Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 1998 0.96
21 Molecular regulation of human IgE synthesis. J Mol Med (Berl) 1997 0.95
22 Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001 0.94
23 Mastocytosis: recent advances in defining the disease. Br J Dermatol 2001 0.94
24 Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol 2005 0.94
25 Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology 1996 0.93
26 Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res 1999 0.93
27 Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol 1996 0.92
28 Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996 0.91
29 Novel unconventional therapeutic approaches to atopic eczema. Dermatology 2000 0.91
30 Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol 1999 0.91
31 Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer 2005 0.91
32 Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. Blood 1998 0.90
33 Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study. Br J Cancer 1998 0.90
34 Microscopic morphology of different types of urticaria. Arch Dermatol 1998 0.90
35 Erythema elevatum diutinum--evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol 2000 0.90
36 Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 1996 0.89
37 Definition, classification, and routine diagnosis of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001 0.89
38 Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998 0.89
39 Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 1996 0.89
40 Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998 0.88
41 The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 2001 0.88
42 Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy. J Histochem Cytochem 1997 0.87
43 Hair growth control by immunosuppression. Arch Dermatol Res 1996 0.87
44 Laser-induced weal and flare reactions: clinical aspects and pharmacological modulation. Br J Dermatol 2002 0.87
45 Human leukaemic (HMC-1) and normal skin mast cells express beta 2-integrins: characterization of beta 2-integrins and ICAM-1 on HMC-1 cells. Scand J Immunol 1997 0.87
46 Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2002 0.87
47 The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci 2005 0.87
48 Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol 1999 0.86
49 Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 1996 0.86
50 Hair cycle-dependent changes in the gene expression and protein content of transforming factor beta 1 and beta 3 in murine skin. Arch Dermatol Res 1997 0.86
51 Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch Dermatol Res 2004 0.85
52 Mastocytosis: review of clinical and experimental aspects. J Investig Dermatol Symp Proc 2001 0.85
53 Medium dose isotretinoin for the treatment of acne. J Eur Acad Dermatol Venereol 1998 0.84
54 GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res 2001 0.84
55 Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol 2004 0.84
56 Neutrophilic urticaria: clinical features, histological changes and possible mechanisms. Br J Dermatol 1998 0.83
57 Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998 0.83
58 Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor. Biochem Biophys Res Commun 1996 0.83
59 Interactions of immature human mast cells with extracellular matrix: expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol 1996 0.83
60 Regulation and possible function of axl expression in immature human mast cells. Ann Hematol 1998 0.83
61 Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol 1999 0.83
62 Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Br J Cancer 2000 0.83
63 AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochem Biophys Res Commun 1996 0.83
64 Phacomatosis pigmentokeratotica: a patient with the rare melanocytic-epidermal twin nevus syndrome. Dermatology 1997 0.82
65 High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996 0.82
66 A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch Dermatol Res 1996 0.82
67 Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol 2001 0.82
68 The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci 1997 0.81
69 Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol 2000 0.81
70 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J Invest Dermatol 1997 0.81
71 Expression of MC1- and MC5-receptors on the human mast cell line HMC-1. Ann N Y Acad Sci 1999 0.81
72 Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. Inflamm Res 2005 0.81
73 Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor. Biochem Biophys Res Commun 2000 0.81
74 Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 2000 0.80
75 Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000 0.80
76 Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000 0.80
77 Adhesion of human mast cells to extracellular matrix provides a co-stimulatory signal for cytokine production. Immunology 1999 0.80
78 Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Immunol 1997 0.79
79 Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol 2001 0.79
80 Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol 2000 0.79
81 Effects of retinoids on in vitro and in vivo IgE production. Int Arch Allergy Immunol 2001 0.79
82 Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol 1999 0.78
83 Retinoic acids and dexamethasone alter cell-surface density of beta 2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells. Arch Dermatol Res 1997 0.78
84 Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion--evidence for retinoid signaling pathways in the mast cell lineage. J Leukoc Biol 2001 0.78
85 Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria. Br J Dermatol 2003 0.78
86 Management of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001 0.78
87 Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids. Skin Pharmacol 1996 0.77
88 Purification of mast cell proteases from murine skin. Exp Dermatol 1999 0.77
89 Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis. Br J Dermatol 2003 0.77
90 Preclinical diagnosis of pseudoxanthoma elasticum - methodological restrictions and ethical problems. Eur J Dermatol 2000 0.77
91 Induction of MHC class II antigen expression on human HMC-1 mast cells. J Dermatol Sci 1997 0.77
92 Adhesion molecules and cellular infiltrate: histology of urticaria. J Investig Dermatol Symp Proc 2001 0.77
93 Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp. Skin Pharmacol Physiol 2004 0.76
94 The promoter of the HaCaT keratinocyte differentiation-related gene keratin 4 contains a functional AP-2 binding site. Arch Dermatol Res 1997 0.76
95 Alterations in ganglioside expression during the differentiation of human mast cells. Exp Dermatol 1999 0.76
96 Leukosialin (CD43) is proteolytically cleaved from stimulated HMC-1 cells. Immunobiology 1997 0.76
97 Effect of granulocyte macrophage colony-stimulating factor in a patient with benign systemic mastocytosis. Br J Dermatol 2001 0.76
98 Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors. Acta Derm Venereol 2001 0.76
99 GM-CSF downregulates expression of tryptase, Fc epsilon RI and histamine in HMC-1 mast cells. Int Arch Allergy Immunol 1997 0.76
100 Retinoic acid affects the expression rate of the differentiation-related genes aryl hydrocarbon receptor, ARNT and keratin 4 in proliferative keratinocytes only. Biochim Biophys Acta 1996 0.76
101 Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells. Cancer Gene Ther 2000 0.76
102 Signal transduction via CD43 (leukosialin, sialophorin) and associated biological effects in human mast cell line (HMC-1). Biochem Biophys Res Commun 1998 0.76
103 [Successful treatment of chronic discoid lupus erythematosus with argon laser]. Hautarzt 1996 0.76
104 Phospholipase C-mediated signaling is altered during HaCaT cell proliferation and differentiation. J Invest Dermatol 1997 0.76
105 CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids. Eur J Immunol 1997 0.76
106 Assessment of psychological aspects during systemic provocation tests in patients with pseudoallergic drug reactions. J Eur Acad Dermatol Venereol 2006 0.75
107 SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts. J Invest Dermatol 1998 0.75
108 Long-term effect of interferon alpha treatment in mastocytosis. Br J Dermatol 1996 0.75
109 Demonstration of the high affinity IgE receptor on Langerhans cells. J Dermatol Sci 1999 0.75
110 Interleukin 7 trials for melanoma treatment. Mol Med Today 1996 0.75
111 Role of antigen-induced cytokine release in atopic pruritus. Int Arch Allergy Immunol 1998 0.75
112 Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor. Scand J Immunol 1998 0.75
113 [Plasmapheresis and immunopathogenetic aspects of toxic epidermal necrolysis]. Hautarzt 1996 0.75
114 [Systemic treatment of acne with isotretinoin: current status]. Hautarzt 1997 0.75
115 Human mast cells and extracellular matrix: immunohistochemical studies of normal skin and inflammatory dermatoses. Br J Dermatol 2004 0.75
116 Acute herpes zoster neuralgia: retrospective analysis of clinical aspects and therapeutic responsiveness. Dermatology 2001 0.75
117 IgE downmodulates stem cell factor-driven mast cell development from cultured peripheral blood mononuclear cells. Int Arch Allergy Immunol 1999 0.75
118 Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. Acta Derm Venereol 1997 0.75
119 [Differences in the groups of chronic urticaria as explanation of divergent results in the search for etiology]. Hautarzt 2001 0.75
120 Nine-year follow-up of a case of Grzybowski type multiple keratoacanthomas and failure to demonstrate human papillomavirus. Br J Dermatol 2002 0.75
121 Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers. Pharmacogenetics 1999 0.75
122 alpha-Melanocyte stimulating hormone acts as a selective inducer of secretory functions in human mast cells. Biochem Biophys Res Commun 2000 0.75
123 Differential endothelial adhesion molecule expression in early and late whealing reactions. Int Arch Allergy Immunol 1998 0.75
124 [Correlation between chronic urticaria and depression/somatization disorder]. Hautarzt 1996 0.75
125 Kerion due to Trichophyton mentagrophytes: responsiveness to fluconazole versus terbinafine in a child. Acta Derm Venereol 2002 0.75
126 Comparison of genetic and immunohistochemical findings in childhood and adult onset urticaria pigmentosa. Int Arch Allergy Immunol 1999 0.75
127 [Pyogenic granuloma recurring with multiple satellites: Nd: YAG laser treatment with ice cube cooling]. Ann Dermatol Venereol 2002 0.75
128 Gene expression and regulation of transcription factor activator protein-2 alpha in human mast cells. Allergy 2005 0.75
129 Absence of MHC class II antigen on mast cells at sites of inflammation in human skin. Exp Dermatol 1996 0.75
130 Retinoic acid attenuates phospholipase C-mediated signaling in HaCaT keratinocytes. Arch Dermatol Res 1997 0.75
131 Hypomelanosis due to block of melanosomal maturation in amiodarone-induced hyperpigmentation. Arch Dermatol 2001 0.75
132 [Women in dermatology. German and other European clinics in a comparison]. Hautarzt 1996 0.75
133 ICAM-3 (CD50) is expressed by human mast cells: induction of homotypic mast cell aggregation via ICAM-3. Cell Adhes Commun 1999 0.75
134 [Histaminosis]. Dtsch Med Wochenschr 1996 0.75
135 [Molecular mechanisms of IgE regulation]. Hautarzt 1997 0.75
136 Immunopathological events of adverse cutaneous reactions to coumarin and heparin. Acta Derm Venereol 1997 0.75